Tevogen Bio Holdings(TVGN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TVGN Tevogen Bio Holdings

盘前交易 11-22 06:48:32 EST

1.64

+0.22

+15.49%

盘前1.64

+0.000.00%

06:41 EST

最高1.70	最低1.36	成交量427.80万
今开1.40	昨收1.42	日振幅23.91%
总市值2.87亿	流通市值2,284万	总股本1.75亿
成交额669.75万	换手率30.71%	流通股本1,393万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TVGN","market":"US","secType":"STK","nameCN":"Tevogen Bio Holdings","latestPrice":1.64,"timestamp":1732222800000,"preClose":1.42,"halted":0,"volume":4277958,"hourTrading":{"tag":"盘前","latestPrice":1.64,"preClose":1.64,"latestTime":"06:41 EST","volume":10648,"amount":17001.9288648,"timestamp":1732275678141},"delay":0,"floatShares":13928200,"shares":175051247,"eps":-0.040796,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.22,"latestTime":"11-22 06:48:32 EST","open":1.4,"high":1.7,"low":1.3605,"amount":6697484.630048401,"amplitude":0.239085,"askPrice":1.76,"askSize":100,"bidPrice":1.59,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.040796,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732285800000},"adr":0,"adjPreClose":1.64,"preHourTrading":{"tag":"盘前","latestPrice":1.64,"preClose":1.64,"latestTime":"06:41 EST","volume":10648,"amount":17001.9288648,"timestamp":1732275678141},"postHourTrading":{"tag":"盘后","latestPrice":1.63,"preClose":1.64,"latestTime":"19:59 EST","volume":129195,"amount":212654.8951,"timestamp":1732237191710},"volumeRatio":0.7668785110274164},"requestUrl":"/m/hq/s/TVGN","defaultTab":"news","newsList":[{"id":"2484954110","title":"Tevogen Bio Holdings Inc.股价上涨21.76% 市值涨6149.18万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484954110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484954110?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:31","pubTimestamp":1732113077,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时31分，Tevogen Bio Holdings Inc.股票出现异动，股价急速拉升21.76%。截至发稿，该股报1.66美元/股，成交量1016.98万股，换手率5.96%，振幅1.10%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022311795be4c8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022311795be4c8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0},{"id":"2484679388","title":"Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484679388","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484679388?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:41","pubTimestamp":1731940870,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时41分，Tevogen Bio Holdings Inc.股票出现异动，股价快速跳水5.21%。截至发稿，该股报1.38美元/股，成交量16.9023万股，换手率0.10%，振幅4.11%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.06%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822411098e4341e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822411098e4341e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0},{"id":"2483208804","title":"Tevogen Bio Holdings Inc.盘中异动 急速跳水5.55%报1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483208804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483208804?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:48","pubTimestamp":1731595681,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时48分，Tevogen Bio Holdings Inc.股票出现异动，股价大幅下挫5.55%。截至发稿，该股报1.70美元/股，成交量23.611万股，换手率0.14%，振幅7.22%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224801abc163b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224801abc163b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2483882007","title":"Tevogen Bio Holdings Inc.盘中异动 早盘快速下挫12.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483882007","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483882007?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:34","pubTimestamp":1731508443,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时34分，Tevogen Bio Holdings Inc.股票出现波动，股价大幅下跌12.92%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322340395be23b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322340395be23b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0},{"id":"2481710436","title":"Tevogen Bio Holdings Inc.盘中异动 股价大跌6.18%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481710436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481710436?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:37","pubTimestamp":1731076670,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时37分，Tevogen Bio Holdings Inc.股票出现波动，股价急速下挫6.18%。截至发稿，该股报1.07美元/股，成交量37.4511万股，换手率0.22%，振幅6.69%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822375098e417ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822375098e417ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":0},{"id":"2481981287","title":"Tevogen Bio Holdings Inc.盘中异动 股价大跌5.18%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481981287","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481981287?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:13","pubTimestamp":1730906003,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日23时13分，Tevogen Bio Holdings Inc.股票出现异动，股价快速下跌5.18%。截至发稿，该股报1.63美元/股，成交量108.58万股，换手率0.64%，振幅9.30%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106231323971a4d14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106231323971a4d14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0},{"id":"2481500334","title":"Tevogen Bio Holdings Inc.盘中异动 股价大涨5.02%报2.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481500334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481500334?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:31","pubTimestamp":1730817073,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时31分，Tevogen Bio Holdings Inc.股票出现波动，股价急速拉升5.02%。截至发稿，该股报2.06美元/股，成交量59.4504万股，换手率0.35%，振幅5.93%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223113a218c3d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223113a218c3d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0},{"id":"2480814575","title":"Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480814575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480814575?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:32","pubTimestamp":1730730778,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时32分，Tevogen Bio Holdings Inc.股票出现波动，股价快速下挫5.80%。截至发稿，该股报2.23美元/股，成交量19.646万股，换手率0.12%，振幅3.80%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223258971a4255&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223258971a4255&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":0},{"id":"2480894908","title":"Tevogen Bio Holdings Inc.盘中异动 早盘大幅下跌5.53%报2.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480894908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480894908?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:34","pubTimestamp":1730468067,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时34分，Tevogen Bio Holdings Inc.股票出现波动，股价急速下跌5.53%。截至发稿，该股报2.39美元/股，成交量17.6363万股，换手率0.10%，振幅1.98%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121342798e3ffec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121342798e3ffec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0},{"id":"2479381740","title":"Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌5.07%报2.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479381740","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479381740?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:45","pubTimestamp":1730382357,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时45分，Tevogen Bio Holdings Inc.股票出现异动，股价急速下跌5.07%。截至发稿，该股报2.34美元/股，成交量80.0171万股，换手率0.47%，振幅8.13%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为2.00%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031214557ab8b9ddc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031214557ab8b9ddc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":1},{"id":"2479301785","title":"Tevogen Bio Holdings Inc.盘中异动 急速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479301785","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479301785?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:37","pubTimestamp":1730295444,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时37分，Tevogen Bio Holdings Inc.股票出现波动，股价急速拉升5.10%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021372498e3f682&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021372498e3f682&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":1},{"id":"2479283963","title":"Tevogen Bio Holdings Inc.盘中异动 早盘股价大涨5.09%报2.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479283963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479283963?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:32","pubTimestamp":1730208722,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时32分，Tevogen Bio Holdings Inc.股票出现异动，股价大幅上涨5.09%。截至发稿，该股报2.88美元/股，成交量40.0282万股，换手率0.23%，振幅3.28%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921320298e3f17a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921320298e3f17a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":1},{"id":"2478548945","title":"Tevogen Bio Holdings Inc.盘中异动 急速下挫11.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478548945","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478548945?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:31","pubTimestamp":1730122314,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时31分，Tevogen Bio Holdings Inc.股票出现波动，股价快速跳水11.28%。截至发稿，该股报2.71美元/股，成交量125.3万股，换手率0.73%，振幅4.59%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821315495bd751d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821315495bd751d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":1},{"id":"2478936321","title":"Tevogen Bio Holdings Inc.盘中异动 大幅下挫6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478936321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478936321?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:31","pubTimestamp":1729863071,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时31分，Tevogen Bio Holdings Inc.股票出现异动，股价急速下挫6.25%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521311195bd58a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521311195bd58a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":1},{"id":"2477514455","title":"BUZZ-Tevogen Bio 因与微软的人工智能合作而飙升","url":"https://stock-news.laohu8.com/highlight/detail?id=2477514455","media":"Reuters","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477514455?lang=zh_cn&edition=full","pubTime":"2024-10-24 01:26","pubTimestamp":1729704403,"startTime":"0","endTime":"0","summary":"    10月23日 - ** 药物开发商Tevogen Bio   股价上涨84.5%，创下2.97美元的逾六个月新高 ** 该公司称其人工智能项目 ，Tevogen AI，已经与微软  在微软初创企业项目下建立了合作伙伴关系。** TVGN表示，双方的合作将为其提供进入微软广泛生态系统的机会** 合作将加速和简化 Tevogen 专有算法的开发，极大地推进我们降低药物开发总成本、加快药物发现的使命。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5abc53af02f97658781648bd1c5130ca","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3S45H60.SGD","IE00BFXG0V08.USD","IE00BDRTCR15.USD","BK4533","TVGN","BK4538","BK4577","IE00B19Z8X17.USD","IE00BLSP4239.USD","BK4579","BK4097","IE0009356076.USD","BK4592","IE00BHPRN162.USD","IE00B5949003.HKD","IE00BJTD4V19.USD","BK4528","IE00BJJMRX11.SGD","BK4576","IE00BJTD4N35.SGD","IE00B19Z8W00.USD","IE00BKPKM429.USD","BK4503","IE000ITXATA3.USD","IE00BDCRKT87.USD","IE00B7KXQ091.USD","GB00B4QBRK32.GBP","BK4535","IE000YTNTUN2.SGD","IE00BK4W5L77.USD","IE00BK4W5M84.HKD","IE00BJJMRY28.SGD","IE00B19Z9505.USD","IE00B775H168.HKD","IE00B1XK9C88.USD","IE0009G5SDU7.USD","IE0034235188.USD","BK4534","IE00B3SWFQ91.USD","BK4588","BK4139","BK4554","IE00B1BXHZ80.USD","BK4587","IE00BKVL7J92.USD","IE0004086264.USD","IE0004091025.USD","IE00B775SV38.USD","BK4585"],"gpt_icon":0},{"id":"2477538149","title":"更正后的简报-Tevogen Bio 在人工智能领域的努力--Tevogen AI 加入微软初创企业，开始加速药物开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2477538149","media":"Reuters","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477538149?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:41","pubTimestamp":1729690880,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) (更正微软 Tevogen Bio 的来源)    路透10月23日 - Tevogen Bio：   * Tevogen Bio 在人工智能领域的努力 Tevogen Ai 加入微软初创公司，开始加速药物开发Eikon 的源文本：","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","IE00B19Z9505.USD","BK4503","IE0034235295.USD","BK4527","IE00BJLML261.HKD","IE0004445239.USD","IE00B7KXQ091.USD","IE00B5949003.HKD","IE0009G5SDU7.USD","BK4592","BK4534","IE00BBT3K403.USD","BK4588","BK4550","BK4516","BK4538","GB00B4QBRK32.GBP","IE00BKVL7J92.USD","IE00BLSP4239.USD","IE00BFSS8Q28.SGD","IE00B3SWFQ91.USD","IE000YTNTUN2.SGD","IE00B19Z8W00.USD","IE00B5TLWC47.USD","BK4587","IE00BJJMRY28.SGD","IE00BK4W5M84.HKD","IE00B4YYXB79.USD","IE00BKDWB100.SGD","IE00BK4W5L77.USD","GB00B4LPDJ14.GBP","BK4528","IE00BFSS7M15.SGD","BK4566","BK4554","IE00BJTD4V19.USD","BK4585","IE000KEQY171.SGD","IE00BKPKM429.USD","IE0009356076.USD","TVGN","IE00BJTD4N35.SGD","BK4504","IE0005OL40V9.USD","BK4577","BK4097","IE000ITXATA3.USD","IE0034235303.USD","MSFT"],"gpt_icon":0},{"id":"2477337920","title":"Tevogen Bio Holdings Inc.盘中异动 股价大跌11.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477337920","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477337920?lang=zh_cn&edition=full","pubTime":"2024-10-22 21:31","pubTimestamp":1729603885,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日21时31分，Tevogen Bio Holdings Inc.股票出现异动，股价急速跳水11.67%。截至发稿，该股报1.59美元/股，成交量108.406万股，换手率0.64%，振幅7.22%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410222131259f56b92d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410222131259f56b92d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":1},{"id":"2477814533","title":"BUZZ-Tevogen Bio 因预计收入近 10 亿美元而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2477814533","media":"Reuters","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477814533?lang=zh_cn&edition=full","pubTime":"2024-10-22 04:37","pubTimestamp":1729543059,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    10月21日 - ** 药物开发商Tevogen Bio   股价收盘上涨约5%，报1.80美元** 公司预测其专科护理产品线在上市当年的收入将接近 10 亿美元** 5 年 累计 收入预计在 180 亿至 220 亿美元之间 - TVGN ** 公司的产品线包括治疗某些癌症患者的 Covid-19 感染以及关节炎。** 截至上一交易日收盘，公司股价年累计下跌 84.2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TVGN"],"gpt_icon":0},{"id":"2477866239","title":"Tevogen Bio Holdings Inc.盘中异动 早盘股价大涨11.05%报1.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477866239","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477866239?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:31","pubTimestamp":1729517496,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时31分，Tevogen Bio Holdings Inc.股票出现异动，股价急速拉升11.05%。截至发稿，该股报1.91美元/股，成交量429.33万股，换手率2.52%，振幅1.16%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121313795b8cca1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121313795b8cca1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":1},{"id":"1123050385","title":"Form 4 | Tevogen Bio Holdings Inc.高管 Neal Flomenberg 减持1078600股","url":"https://stock-news.laohu8.com/highlight/detail?id=1123050385","media":"老虎公告助手","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123050385?lang=zh_cn&edition=full","pubTime":"2024-10-19 10:00","pubTimestamp":1729303211,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings Inc.高管Neal Flomenberg于2024年10月17日按照1.62美元的加权平均价格出售了1,078,600股普通股票，出售价格范围在1.50至1.74美元。此次减持后的股票持有量为4,254,302股。高管减持股票通常被视为一个潜在负面信号，投资者需注意公司当前股价可能高估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://semperparatusspac.com","stockEarnings":[{"period":"1week","weight":0.1081},{"period":"1month","weight":0.0186},{"period":"3month","weight":1.8276},{"period":"6month","weight":1},{"period":"1year","weight":-0.8508},{"period":"ytd","weight":-0.8527}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tevogen Bio Holdings Inc.于2021年4月21日在开曼群岛注册成立，后合并重组为特拉华州公司。Tevogen Bio是一家临床阶段的专业免疫疗法公司，利用自然界最强大的免疫武器之一—CD8 +细胞毒性T淋巴细胞，开发现成的、未经基因改造的精准T细胞疗法，用于治疗传染病、癌症和神经系统疾病，旨在解决大量患者群体的重大未满足需求。","exchange":"NASDAQ","name":"Tevogen Bio Holdings","nameEN":"Tevogen Bio Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tevogen Bio Holdings(TVGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tevogen Bio Holdings(TVGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tevogen Bio Holdings,TVGN,Tevogen Bio Holdings股票,Tevogen Bio Holdings股票老虎,Tevogen Bio Holdings股票老虎国际,Tevogen Bio Holdings行情,Tevogen Bio Holdings股票行情,Tevogen Bio Holdings股价,Tevogen Bio Holdings股市,Tevogen Bio Holdings股票价格,Tevogen Bio Holdings股票交易,Tevogen Bio Holdings股票购买,Tevogen Bio Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tevogen Bio Holdings(TVGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tevogen Bio Holdings(TVGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}